This article was originally published in The Gray Sheet
Executive SummaryCaverMap surgical aid for use in sparing vital nerves during prostate surgery will be launched at the American Urological Association meeting in San Diego May 30-June 4. The Needham, Massachusetts firm begins a six-center clinical study involving over 100 patients designed to "quantify the benefits to patients and surgeons utilizing" the device, which received FDA clearance in October ("The Gray Sheet" Nov. 3, 1997, I&W-11)...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.